Britta A. Mattson

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients

Matthew Kennedy, Andrew W. Stamford, Xia Chen et al. · Science Translational Medicine · 2016 · 407 citations

Glucose Homeostasis, Bace1 Inhibitor Verubecestat, Enzyme 1 +20

Oogenesis: Chromatin and microtubule dynamics during meiotic prophase

Britta A. Mattson, David F. Albertini · Molecular Reproduction and Development · 1990 · 298 citations

Diet, Overfeeding, and Moderate Dietary Restriction in Control Sprague-Dawley Rats: II. Effects on Age-Related Proliferative and Degenerative Lesions

Kevin P. Keenan, Keith A. Soper, Phillip R. Hertzog et al. · Toxicologic Pathology · 1995 · 95 citations

Nutrition, Aging, Biogerontology +18

Mechanism based neurotoxicity of mGlu5 positive allosteric modulators – Development challenges for a promising novel antipsychotic target

Sophie Parmentier‐Batteur, Peter H. Hutson, Karsten Menzel et al. · Neuropharmacology · 2013 · 93 citations

Molecular Pharmacology, Molecular Neuroscience, Development Challenges +11

Autoradiographic Evidence for Insulin and Insulin-Like Growth Factor Binding to Early Mouse Embryos

Britta A. Mattson, Ira Rosenblum, Robert M. Smith et al. · Diabetes · 1988 · 90 citations

Embryo Culture, Early Mouse Embryos, Preimplantation Embryos +15